Insider · CIK 0001218981
John S Stafford III
Files at AWRE (AWARE INC /MA/). First filing Mar 14, 2025, latest May 14, 2026.
John S Stafford III files SEC Form 4 as director at AWRE (AWARE INC /MA/). Since Mar 14, 2025, John S Stafford III has reported 4 open-market buys worth $161k and 0 open-market sells worth $0, the latest filed on May 14, 2026.
A track record needs three past buys with six months of prices behind them; John S Stafford III has 0, so none is measured yet.
The newest scored trade: bought $101k of AWRE on May 13, 2026, filed May 14, 2026, scored 56 (moderate). In the last 12 months: 3 buys worth $146k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AWRE: AWARE INC /MA/
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 56Moderate | AWARE INC /MA/ | $101k 80,412 shares | +2% | +10% from low-57% from high | |
| 41Moderate | AWARE INC /MA/ | $24k 19,588 shares | +0% | +10% from low-57% from high | |
| 36Weak | AWARE INC /MA/ | $21k 16,754 shares | +0% | 0% from low-53% from high | |
| 33Weak | AWARE INC /MA/ | $14k 8,758 shares | +0% | +10% from low-32% from high |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 13, 2026 | AWRE AWARE INC /MA/ | POpen-market purchase Common Stock | +22,475 | $1.25 | $28k | 5,164,017 | May 14, 2026 |
| May 14, 2026 | AWRE AWARE INC /MA/ | POpen-market purchase Common Stock | +57,937 | $1.25 | $72k | 5,221,954 | May 14, 2026 |
| May 4, 2026 | AWRE AWARE INC /MA/ | POpen-market purchase Common Stock | +15,720 | $1.25 | $20k | 5,137,674 | May 7, 2026 |
| May 5, 2026 | AWRE AWARE INC /MA/ | POpen-market purchase Common Stock | +3,868 | $1.25 | $4,835 | 5,141,542 | May 7, 2026 |
| Mar 13, 2026 | AWRE AWARE INC /MA/ | POpen-market purchase Common Stock | +16,754 | $1.28 | $21k | 5,121,954 | Mar 17, 2026 |
| Feb 23, 2026 | AWRE AWARE INC /MA/ | AGrant or award Unrestricted Stock Awardderivative | +39,118 | $0.00 | $0 | 39,118 | Feb 25, 2026 |
| Jan 2, 2026 | AWRE AWARE INC /MA/ | MOption exercise Common Stock | +22,316 | $0.00 | $0 | 5,105,200 | Jan 5, 2026 |
| Jul 1, 2025 | AWRE AWARE INC /MA/ | MOption exercise Common Stock | +22,315 | $0.00 | $0 | 5,082,884 | Jul 2, 2025 |
| Mar 12, 2025 | AWRE AWARE INC /MA/ | POpen-market purchase Common Stock | +8,758 | $1.65 | $14k | 5,060,569 | Mar 14, 2025 |
| Mar 4, 2025 | AWRE AWARE INC /MA/ | AGrant or award Unrestricted Stock Awardderivative | +44,631 | $0.00 | $0 | 44,631 | Mar 6, 2025 |
| Jan 2, 2025 | AWRE AWARE INC /MA/ | MOption exercise Common Stock | +11,862 | $0.00 | $0 | 5,051,801 | Jan 3, 2025 |
Questions about John S Stafford III
Answered from the filings on this page, as of the latest one.
Is John S Stafford III buying or selling?
In the last 12 months John S Stafford III reported 3 open-market buys worth $146k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $101k of AWRE on May 13, 2026. Grants, option exercises and tax withholding are not counted.
How did John S Stafford III's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John S Stafford III has 0.
Where does John S Stafford III file Form 4?
John S Stafford III has filed Form 4 at AWRE (AWARE INC /MA/). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.